Fosun Pharma
Search results
Fosun International Limited is a Chinese multinational conglomerate holding company. Founded in 1992 by Guo Guangchang and four others, the company is headquartered in Shanghai and was incorporated in Hong Kong in 2004.
Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of one billion families in health, happiness and wealth. In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK).
Fosun for Good, Sharing Happiness. Fosun upholds its original aspirations of developing business for good and “Contribution to Society”, endeavoring to create happier lives for families worldwide
Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of one billion families in health, happiness and wealth. In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK).
Fosun International Limited
Find the latest Fosun International Limited (0656.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.
FOSUN INTERNATIONAL LIMITEDANNUAL REPORT 2021 Letter to Shareholders In 2021, Fosun established the Overseas Operation Committee to expedite Fosun’s global organizational evolution and foster the multiplier growth of its global business. Fosun’s international team and ecosystem members are the core of Fosun’s globalization capabilities.
Full details of the annual results announcement of Fosun International can be found on the Company’s website (www.fosun.com) and on the website of the Hong Kong Stock Exchange. Fosun International 2022 annual results presentation will be held on 30 March 2023, from 10:00 to 16:00.
In 2023, Fosun’s four core subsidiaries continued to focus on business and enhance operational capabilities, and saw significant revenue growth. Yuyuan’s jewlery & fashion group revenue reached RMB36.7 billion, representing a year-on-year increase of 11%.
Transform the industry with technology to create healthier lives. Driven by technology innovation, the Health segment focuses on the three major areas of pharmaceutical, devices and diagnosis, and healthcare services and products. Pharmaceutical Manufacturing. Devices & Diagnosis.
